Biotechnology News

November 21, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme’s Once-Daily, Oral AUBAGIO® Approved in Australia for Treatment of Relapsing Multiple Sclerosis

November 21, 2012

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Dr. Leonard Bell, Chief Executive Officer of Alexion Pharmaceuticals, will present at the 24th Annual Piper Jaffray Healthcare Conference in New...

November 21, 2012

MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG) (the “Company”), the developer of BiopumpTM a novel technology for the sustained production and delivery of therapeutic proteins in...

November 21, 2012

BOCA RATON, Fla.--(BUSINESS WIRE)--The CNS Summit is focused on improving the success of researchers bringing new treatments to patients suffering from CNS disorders. The 2012 Summit successfully occurred November 15-18 in Boca Raton.

November 21, 2012

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix International N.V., (NASDAQ:OFIX) (the Company) announced today that President and Chief Executive Officer Robert Vaters will present at the Piper Jaffray 24th Annual Healthcare Conference on Wednesday...

November 21, 2012

CONCORD, Calif.--(BUSINESS WIRE)--Cerus (NASDAQ:CERS) is scheduled to present at the Piper Jaffray Healthcare Conference in New York at 9:00 AM ET on Wednesday, November 28, 2012.

November 21, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Senesco Technologies, Inc. (“Senesco” or the “Company”) (OTC:SNTI) announced that as of Wednesday, November 21, 2012, the Company’s common stock will be quoted on the OTC.QB under the ticker symbol SNTI. Quotes...

November 21, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that it will collaborate with Perrigo Company (NASDAQ: PRGO;TASE) on the development, manufacturing and commercialization of an extended topical generic...

November 21, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company dedicated to developing and commercializing first-in-class oncology therapeutics, today announced that it has been issued a...

November 21, 2012

LINKÖPING, Sweden--(BUSINESS WIRE)--A research team at the Karolinska Institute in Stockholm has conducted a study that shows how Sectra’s online service, Sectra OneScreen, provides an efficient and inexpensive method for early identification of...

November 21, 2012

SAN MARINO, Calif.--(BUSINESS WIRE)--Revised capital structure to facilitate establishing strategic alliances, new business development and hiring of new executive team.

November 20, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics to Present at the Piper Jaffray 24th Annual Healthcare Conference

November 20, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer Establishes New Direct Operations in Southern Africa to Expand Its Presence & Business in the Fast Developing Region

November 20, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will present at the Piper Jaffray 24th Annual Healthcare Conference on Tuesday, November 27, at 8:00 a.m. Eastern Standard Time. The...

November 20, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Affymax, Inc. (Nasdaq: AFFY) today announced the company’s participation in the following investors conferences. 24th Annual Piper Jaffray Health Care ConferenceTuesday, November 27, 2012 in New York City10:00...

November 20, 2012

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets...

November 20, 2012

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb (NYSE: BMY) and Pfizer (NYSE: PFE) announced today that the European Commission has approved ELIQUIS® (apixaban) for prevention of stroke and systemic embolism in adult...

November 20, 2012

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides reports filing of quarterly report and having sufficient cash in hand to advance its drug development programs.

November 20, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Health outcomes liaisons (HOLs) spend nearly an hour per visit with their clients, according to a report released by Cutting Edge Information.

November 20, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Allenex AB (STO:ALNX): For the third quarter July - September Net sales for the quarter amounted to SEK 26.7 million (26.3), corresponding to a 1.5 percent increase compared to the same period last...

November 20, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--LifeMap Sciences, Inc. a subsidiary of BioTime, Inc. (NYSE MKT: BTX) announced today that it has signed a definitive distribution agreement with ProSpec-Tany TechnoGene Ltd. (ProSpec). In the beginning of 2013,...

November 20, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem, Inc., (NASDAQ: VSTM) a clinical-stage biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that researchers at...

November 20, 2012

TWINSBURG, Ohio--(BUSINESS WIRE)--A patent has been awarded to L.J. Star for its TCI ClampConnect™, a sanitary fitting that makes sterile/clean in place processes more sanitary by eliminating the dead leg of ordinary ferrule fittings that can...

November 20, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics is teaming up with PPD to resume its Phase IIb clinical trials using Oxycyte for traumatic brain injury. TBI is known as the signature wound of war.

November 20, 2012

HENNIGSDORF, Germany--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. today announced it has signed a long-term license agreement with Fujirebio Inc. to make its biomarker assay Procalcitonin (PCT) available in Japan.

November 20, 2012

SAN DIEGO--(BUSINESS WIRE)--MNTR signs $6 million Letter of Intent with nanotechnology cancer leader Nanovega, Inc. Nano-sized particles tag cancer cells and slip into solid tumors instead of bunching up on the cancer surface.

November 20, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, announced today that Edward J. Quilty, the Company’s chief executive officer, will present at the...

November 20, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix and CPGR in South Africa collaborate to enable genomics research for scientists across Africa to discover genetic markers specific in the African population for personalized medicine.

November 20, 2012

NESS ZIONA, Israel--(BUSINESS WIRE)--Atox Bio today reported positive top-line results from the AB103 randomized, double-blind, placebo-controlled Phase 2a trial in patients with Necrotizing Soft Tissue Infections (NSTI), a life-threatening...

November 20, 2012

LONDON--(BUSINESS WIRE)--New market research report “Innovative Hematology and Flow Cytometry Technologies and Emerging Markets” created by Venture Planning Group has been recently published at MarketPublishers.com

November 20, 2012

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Jane Wasman, President, International and General Counsel will present at the Piper Jaffray 24th Annual Healthcare Conference on Wednesday, November 28...

November 20, 2012

PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN, ADR: IPSEY) (Paris:IPN) and Inspiration Biopharmaceuticals Inc. (Inspiration) today announced that Inspiration has received Fast Track designation from the US...

November 19, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cordis today announced the presentation of the INCRAFT™ AAA Stent-Graft System INNOVATION study one-year results at the 2012 Veith Symposium in New York City.

November 19, 2012

NORTH LIBERTY, Iowa--(BUSINESS WIRE)--KemPharm, Inc. receives positive feedback from FDA on KP201 Clinical Plan

November 19, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE MKT: SNT) received verbal notice from NYSE MKT LLC of the exchange’s decision to delist the Company’s common stock from the NYSE MKT, effective...

November 19, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today announced that Mark Goldberg, M.D., Senior Vice President...

November 19, 2012

DURHAM, N.C.--(BUSINESS WIRE)--Dr. Seth Rudnick has joined the Board of Directors of both Square 1 Financial, Inc. and Square 1 Bank. He has an extensive background in the venture capital industry, 30+ years in pharma and biotech

November 19, 2012

CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Diffusion Pharmaceuticals LLC, a biotechnology company developing innovative cancer treatments, today announced that it has successfully completed a Phase I clinical trial of its lead compound trans sodium...

November 19, 2012

ATLANTA & NEW YORK & DENVER--(BUSINESS WIRE)--The National Down Syndrome Congress, the National Down Syndrome Society and the Global Down Syndrome Foundation announced a collaborative effort to address prenatal testing issues.

November 19, 2012

MUNICH--(BUSINESS WIRE)--The Image-Com 5.0 software is the newest addition to TomTec’s Image-Arena image management solution.

November 19, 2012

LAGUNA BEACH, Calif.--(BUSINESS WIRE)--3V07 Healthcare Advertising Add Ian Koff as New Creative Director

November 19, 2012

NEW YORK--(BUSINESS WIRE)--On November 19, 2012, the Juvenile Diabetes Cure Alliance announced the release of their annual research report, State of the Cure, which is the only analytical and comprehensive review of progress made toward a type 1...

November 19, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in contrast to surveyed managed care organization (MCO) pharmacy directors’...

November 19, 2012

DUSSELDORF, Germany--(BUSINESS WIRE)--The Ministry of Industry and Trade of the Russian Federation led a united Russian delegation at the world’s largest medical trade fair MEDICA 2012 and presented the OPEN RUSSIA DAY. In the forthcoming years,...

November 19, 2012

CHICAGO--(BUSINESS WIRE)--Clontech has adopted SnapGene for cloning simulation and plasmid map drawing, and has endorsed SnapGene as the ideal partner for their In-Fusion cloning kits.

November 19, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the release of GeneCards®, Version 3.09, on November 18, 2012. The new release is available at...

November 19, 2012

PARIS--(BUSINESS WIRE)--The 17th annual Longevity Prize of the Fondation Ipsen has been awarded to Linda Fried (Columbia University, New York, USA), in recognition of her outstanding leadership in the domain of the frailty syndrome, by an...

November 19, 2012

MADISON, Wis.--(BUSINESS WIRE)--BioForward announced today that Fritz Bittenbender, Vice President of Alliance Development and State Government Affairs for BIO